journal article·2024-11-25Open access

Regulation of Oxygen in the Tumor Microenvironment Synergizes with Immunotherapy to Suppress Tumor Progression

Shoucheng Wang, Yongjie Chi, Danyang Wang, Kai Zhao, Lianyan Wang

Journal of Functional Biomaterials· Volume 15· Issue 12

Abstract

Hypoxia represents a crucial characteristic of the tumor microenvironment, which is closely related to cell proliferation, angiogenesis, and metabolic responses. These factors will further promote tumor progression, increase tumor invasion, and enhance tumor metastasis potential. A hypoxic microenvironment will also inhibit the activity of infiltrated immune cells in the tumor microenvironment, leading to the failure of cancer immunotherapy. Additionally, the hypoxic tumor microenvironment contributes to resistance to conventional therapies and leads to unfavorable prognoses. This review discusses advancements in strategies aimed at ameliorating tumor hypoxia within the microenvironment and modulating immune cell responses against tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education, Heilongjiang University, Harbin 150500, China

Key Laboratory of Microbiology, College of Heilongjiang Province, School of Life Sciences, Heilongjiang University, Harbin 150080, China

Taizhou Key Laboratory of Biomedicine and Advanced Dosage Forms, School of Life Sciences, Taizhou University, Taizhou 318000, China

Key Laboratory of Green Process and Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China

School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

Funding

Beijing Municipal Education Commission · Industrial Science and Technology Program in Taizhou

References (52)

Show source-provided references
1. Hypoxia and the Tumor Microenvironment10.1177/15330338211036304 ↗
2. Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response10.3389/fimmu.2022.903105 ↗
3. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy10.1016/j.apsb.2022.11.001 ↗
4. Unlocking the potential of the tumor microenvironment for cancer therapy10.1016/j.prp.2023.154846 ↗
5. Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting10.1016/j.trsl.2023.10.003 ↗
6. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy10.1016/j.semcancer.2023.11.008 ↗
7. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment10.1016/j.intimp.2020.106939 ↗
8. A reductionist perspective on HIF-1α’s role in cell proliferation under non-hypoxic conditions10.1016/j.bbamcr.2024.119683 ↗
9. HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −1110.1016/j.biopha.2024.116427 ↗
10. Biomedical engineered nanomaterials to alleviate tumor hypoxia for enhanced photodynamic therapy10.1016/j.phrs.2022.106551 ↗
11. Nanomaterials relieving hypoxia for enhanced tumor therapy10.1016/j.ccr.2023.215482 ↗
12. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance10.1016/j.biomaterials.2018.08.004 ↗
13. A hemoglobin-based oxygen-carrying biomimetic nanosystem for enhanced chemo-phototherapy and hypoxia alleviation of hepatocellular carcinoma10.1016/j.jiec.2023.03.050 ↗
14. Hypoxia-alleviating hemoglobin nanoclusters for sensitizing chemo-photodynamic therapy of cervical cancer10.1016/j.cej.2022.141224 ↗
15. Upconverting nanoparticle-containing erythrocyte-sized hemoglobin microgels that generate heat, oxygen and reactive oxygen species for suppressing hypoxic tumors
16. Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers10.1016/j.coph.2020.08.010 ↗
17. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies10.1021/acs.nanolett.6b02365 ↗
18. Erythrocyte-Membrane-Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy10.1002/adma.201701429 ↗
19. Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy10.1016/j.biomaterials.2021.121250 ↗
20. Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation10.1002/advs.201800049 ↗
21. Photoacoustic nanodroplets for oxygen enhanced photodynamic therapy of cancer10.1016/j.pacs.2021.100306 ↗
22. Mitochondria-Targeting Oxygen-Sufficient Perfluorocarbon Nanoparticles for Imaging-Guided Tumor Phototherapy10.2147/IJN.S281649 ↗
23. Hydroxyl radical generations form the physiologically relevant Fenton-like reactions10.1016/j.freeradbiomed.2023.09.013 ↗
24. Fe-doped nanodiamond-based photo-Fenton catalyst for dual-modal fluorescence imaging and improved chemotherapeutic efficacy against tumor hypoxia10.1039/D3RA08465E ↗
25. Cyclic reactions-mediated self-supply of H2O2 and O2 for cooperative chemodynamic/starvation cancer therapy10.1016/j.biomaterials.2021.120987 ↗
26. Erythrocyte Membrane-Camouflaged PCN-224 Nanocarriers Integrated with Platinum Nanoparticles and Glucose Oxidase for Enhanced Tumor Sonodynamic Therapy and Synergistic Starvation Therapy10.1021/acsami.1c05644 ↗
27. Overcoming Hypoxia-Restrained Radiotherapy Using an Erythrocyte-Inspired and Glucose-Activatable Platform10.1021/acs.nanolett.0c00650 ↗
28. Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response10.1021/nn405773r ↗
29. Ultrathin-FeOOH-Coated MnO2 Sonosensitizers with Boosted Reactive Oxygen Species Yield and Remodeled Tumor Microenvironment for Efficient Cancer Therapy10.1002/advs.202200005 ↗
30. Dual-Stage Light Amplified Photodynamic Therapy against Hypoxic Tumor Based on an O2 Self-Sufficient Nanoplatform10.1002/smll.201701621 ↗
31. Polymer-coated calcium peroxide nanoparticles as an oxygen self-supplying platform for enhanced photodynamic therapy10.1016/j.eurpolymj.2022.111458 ↗
32. Recent Biomaterial-Assisted Approaches for Immunotherapeutic Inhibition of Cancer Recurrence10.1021/acsbiomaterials.3c01347 ↗
33. Li, X. (Acta Biomater., 2024). Dual-activity nanozyme as an oxygen pump to alleviate tumor hypoxia and enhance photodynamic/NIR-II photothermal therapy for sniping oral squamous cell carcinoma, Acta Biomater., in press.10.1016/j.actbio.2024.10.018 ↗
34. Confined semiconducting polymers with boosted NIR light-triggered H2O2 production for hypoxia-tolerant persistent photodynamic therapy10.1039/D4SC01609B ↗
35. In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation10.1016/j.carbpol.2022.119418 ↗
36. Responsive agarose hydrogel incorporated with natural humic acid and MnO2 nanoparticles for effective relief of tumor hypoxia and enhanced photo-induced tumor therapy10.1039/C9BM01472A ↗
37. Mnox Nanoenzyme Armed CAR-NK Cells Enhance Solid Tumor Immunotherapy by Alleviating the Immunosuppressive Microenvironment10.1002/adhm.202303963 ↗
38. Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids10.1021/acs.molpharmaceut.1c00085 ↗
39. Cleavable bimetallic-organic polymers for ROS mediated cascaded cancer therapy under the guidance of MRI through tumor hypoxia relief strategy10.1007/s11426-020-9735-2 ↗
40. Self-Supply of O2 and H2 O2 by a Nanocatalytic Medicine to Enhance Combined Chemo/Chemodynamic Therapy10.1002/advs.201902137 ↗
41. Oxygen-Evolving Mesoporous Organosilica Coated Prussian Blue Nanoplatform for Highly Efficient Photodynamic Therapy of Tumors10.1002/advs.201700847 ↗
42. Calcium Phosphate-Reinforced Metal-Organic Frameworks Regulate Adenosine-Mediated Immunosuppression10.1002/adma.202102271 ↗
43. P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer10.1016/j.celrep.2016.02.016 ↗
44. Hypoxia, a key factor in the immune microenvironment10.1016/j.biopha.2022.113068 ↗
45. Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity10.1016/j.jconrel.2023.05.013 ↗
46. Cell Cycle Regulation Meets Tumor Immunosuppression10.1016/j.it.2020.07.010 ↗
47. Lycium barbarum L. polysaccharide LBP3 exerts the anti-tumor effect through enhancing the function of tumor-associated dendritic cells via inhibiting IRE1α -XBP1 pathway of ER stress10.1016/j.jff.2023.105950 ↗
48. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis10.1016/j.cell.2015.05.025 ↗
49. Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor-Specific Therapy10.1002/adma.202008065 ↗
50. Dual targeting of CTLA-4 and CD47 on T reg cells promotes immunity against solid tumors10.1126/scitranslmed.abg8693 ↗
51. Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages10.1158/0008-5472.CAN-20-1723 ↗
52. A programmable releasing versatile hydrogel platform boosts systemic immune responses via sculpting tumor immunogenicity and reversing tolerogenic dendritic cells10.1016/j.biomaterials.2023.122444 ↗